Anke Unger

1.4k citations

24 papers · 383 indexed · h-index 12

Impact in

Clinical Biochemistry top 10%
- Advanced Glycation End Products research
Sensory Systems
- Ion Channels and Receptors

Papers in ⓘ

Biological Psychiatry 1
Oncology 9
- Cytokine Signaling Pathways and Interactions 5

Co-authors: Stefan Laufer (4 shared papers)Markus O. Lederer (1 shared paper)Bert Klebl (11 shared papers)Wolfgang Albrecht (3 shared papers)Matthias Baumann (5 shared papers)Jan Eickhoff (6 shared papers)Isabel Zeitträger (1 shared paper)Klaus Korn (1 shared paper)
Journals: Journal of Medicinal Chemistry (6 papers)European Journal of Medicinal Chemistry (2 papers)Oncotarget (2 papers)Cell Host & Microbe (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
Partner nations: Germany Norway United Kingdom

In The Last Decade

Anke Unger

22 papers receiving 380 citations

Peers

Countries citing papers authored by Anke Unger

Since Specialization

Citations

This map shows the geographic impact of Anke Unger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Unger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Unger more than expected).

Fields of papers citing papers by Anke Unger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anke Unger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Unger. The network helps show where Anke Unger may publish in the future.

Co-authors

The 25 scholars most cited alongside Anke Unger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anke Unger Line = papers co-authored together Anke Unger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A Novel CDK7 Inhibitor of the Pyrazolotriazine Class Exerts Broad-Spectrum Antiviral Activity at Nanomolar Concentrations Antimicrobial Agents and Chemotherapy ·Corina Hutterer, Jan Eickhoff, Jens Milbradt, Klaus Korn, Isabel Zeitträger, Hanife Bahsi, Sabrina Wagner, Gunther Zischinsky, Alexander Wolf, Carsten Degenhart, Anke Unger, Matthias Baumann, Bert Klebl, Manfred Marschall	2015	92
2	Identification and Quantification of Phosphatidylethanolamine-Derived Glucosylamines and Aminoketoses from Human Erythrocytes—Influence of Glycation Products on Lipid Peroxidation Archives of Biochemistry and Biophysics ·C. Breitling‐Utzmann, Anke Unger, D. Alexander Friedl, Markus O. Lederer	2001	58
3	Combined Human Genome-wide RNAi and Metabolite Analyses Identify IMPDH as a Host-Directed Target against Chlamydia Infection Cell Host & Microbe ·Marion Rother, Erik Gonzalez, Ana Rita Teixeira da Costa, Lea Wask, Isabella Gravenstein, Matteo Pardo, Matthias Pietzke, Rajendra Kumar Gurumurthy, Jörg Angermann, Robert Laudeley, Silke Glage, Michaël Meyer, Cindrilla Chumduri, Stefan Kempa, Klaus Dinkel, Anke Unger, Bert Klebl, Andreas Klos, Thomas F. Meyer	2018	33
4	TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A Oncotarget ·Sin Ying Cheung, Matthias Henrot, Mohammad Alsaad, Matthias Baumann, Heiko Müller, Anke Unger, Hussein N. Rubaiy, Ilka Mathar, Klaus Dinkel, Peter Nußbaumer, Bert Klebl, Marc Freichel, Baptiste Rode, Sebastian Trainor, Steven J. Clapcote, Mathias Christmann, Herbert Waldmann, S. K. Abbas, David J. Beech, Naveen Vasudev	2018	25
5	Structure-Guided Development of Covalent and Mutant-Selective Pyrazolopyrimidines to Target T790M Drug Resistance in Epidermal Growth Factor Receptor Journal of Medicinal Chemistry ·Julian Engel, Steven P. Smith, Jonas Lategahn, Hannah L. Tumbrink, Lisa Goebel, Christian Becker, Elisabeth Hennes, Marina Keul, Anke Unger, Heiko Müller, Matthias Baumann, Carsten Schultz‐Fademrecht, Georgia Günther, Jan G. Hengstler, Daniel Rauh	2017	25
6	Impact of p38 MAP Kinase Inhibitors on LPS-Induced Release of TNF-α in Whole Blood and Primary Cells from Different Species Cellular Physiology and Biochemistry ·Sarah Fehr, Anke Unger, Elke Schaeffeler, Sonja Herrmann, Stefan Laufer, Matthias Schwab, Wofgang Albrecht	2015	22
7	2‐Acylaminopyridin‐4‐ylimidazoles as p38 MAP Kinase Inhibitors: Design, Synthesis, and Biological and Metabolic Evaluations ChemMedChem ·Katharina Ziegler, Dominik Hauser, Anke Unger, Wolfgang Albrecht, Stefan Laufer	2009	22
8	Discovery of N-{4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a Dual p38α MAPK/PDE-4 Inhibitor with Activity against TNFα-Related Diseases Journal of Medicinal Chemistry ·Wolfgang Albrecht, Anke Unger, Silke M. Bauer, Stefan Laufer	2017	17
9	Chronic high dose P2X7 receptor inhibition exacerbates cancer-induced bone pain European Journal of Pharmacology ·Sarah Falk, Camilla Kristine Appel, Heidi Bahrt Bennedbæk, Tamara Al-Dihaissy, Anke Unger, Klaus Dinkel, Anne‐Marie Heegaard	2018	15
10	Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach Journal of Medicinal Chemistry ·Jonas Lategahn, Julia Hardick, Tobias Grabe, Janina Niggenaber, Kirujan Jeyakumar, Marina Keul, Hannah L. Tumbrink, Christian Becker, Luke Hodson, Tonia Kirschner, Philip Klövekorn, Julia Ketzer, Matthias Baumann, Susanne Terheyden, Anke Unger, Jörn Weisner, Matthias Müller, Willem A. L. van Otterlo, Sebastian Bauer, Daniel Rauh	2020	12
11	In Vitro Metabolism of 2-[6-(4-Chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl] Acetic Acid (Licofelone, ML3000), an Inhibitor of Cyclooxygenase-1 and -2 and 5-Lipoxygenase Drug Metabolism and Disposition ·Wolfgang Albrecht, Anke Unger, Andreas K. Nüssler, Stefan Laufer	2008	11
12	Targeting Gain of Function and Resistance Mutations in Abl and KIT by Hybrid Compound Design Journal of Medicinal Chemistry ·André Richters, Julia Ketzer, Matthäus Getlik, Christian Grütter, R. Schneider, Johannes M. Heuckmann, Stefanie Heynck, Martin L. Sos, Anu Gupta, Anke Unger, Carsten Schultz‐Fademrecht, Roman K. Thomas, Sebastian Bauer, Daniel Rauh	2013	11
13	Structure–Activity Relationship Studies of Trisubstituted Isoxazoles as Selective Allosteric Ligands for the Retinoic-Acid-Receptor-Related Orphan Receptor γt Journal of Medicinal Chemistry ·Femke A. Meijer, Annet O.W.M. Saris, Richard G. Doveston, Guido J.M. Oerlemans, R.M.J.M. de Vries, B. Somsen, Anke Unger, Bert Klebl, Christian Ottmann, Peter J. Cossar, Luc Brunsveld	2021	9
14	A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiation European Journal of Medicinal Chemistry ·Thomas Ihle Aarhus, Jan Eickhoff, Bert Klebl, Anke Unger, Joanna Boros, Axel Choidas, Mia‐Lisa Zischinsky, Camilla Wolowczyk, Geir Bjørkøy, Eirik Sundby, Bård Helge Hoff	2023	7
15	Synthesis and Development of Highly Selective Pyrrolo[2,3-d]pyrimidine CSF1R Inhibitors Targeting the Autoinhibited Form Journal of Medicinal Chemistry ·Thomas Ihle Aarhus, Frithjof Bjørnstad, Camilla Wolowczyk, Kristin Uhlving Larsen, Line Rognstad, Trygve Leithaug, Anke Unger, Peter Habenberger, Alexander Wolf, Geir Bjørkøy, Clare Pridans, Jan Eickhoff, Bert Klebl, Bård Helge Hoff, Eirik Sundby	2023	6
16	Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia Oncotarget ·Joachim R. Göthert, Roze Imsak, Michael Möllmann, Stefanie Kesper, Maria Göbel, Ulrich Dührsen, Arne Scholz, Ulrich Lücking, Matthias Baumann, Anke Unger, Carsten Schultz‐Fademrecht, Bert Klebl, Jan Eickhoff, Axel Choidas, Jan Dürig	2018	5
17	Discovery of tetrazolo-pyridazine-based small molecules as inhibitors of MACC1-driven cancer metastasis Biomedicine & Pharmacotherapy ·Shixian Yan, Paul Curtis Schöpe, Joe Lewis, Kerstin Putzker, Ulrike Uhrig, Edgar Specker, Jens Peter von Kries, Peter Lindemann, Anahid Omran, Héctor E. Sánchez-Ibarra, Anke Unger, Mia‐Lisa Zischinsky, Bert Klebl, Wolfgang Walther, Marc Nazaré, Dennis Kobelt, Ulrike Stein	2023	4
18	Negishi Cross‐Coupling in the Preparation of Benzyl Substituted Pyrrolo[2,3‐d]pyrimidine Based CSF1R Inhibitors European Journal of Organic Chemistry ·Thomas Ihle Aarhus, Vilde Teksum, Anke Unger, Peter Habenberger, Alexander Wolf, Jan Eickhoff, Bert Klebl, Camilla Wolowczyk, Geir Bjørkøy, Eirik Sundby, Bård Helge Hoff	2023	4
19	Protection of pancreatic islets from oxidative cell death by a peripherally-active morphinan with increased drug safety Molecular Metabolism ·O Scholz, Elena Huß, Silke Otter, Diran Herebıan, Anna B. Hamacher, Laura M. Levy, Stanimira Hristeva, Miguel Sanz, Haresh Ajani, Alfredo Rodriguez Puentes, Torsten Hoffmann, Jens Hogeback, Anke Unger, Susanne Terheyden, Michelle Reina do Fundo, Bedair Dewidar, Michael Roden, Eckhard Lammert	2023	1
20	Pyrrolopyrimidine based CSF1R inhibitors: Attempted departure from Flatland European Journal of Medicinal Chemistry ·Frithjof Bjørnstad, Simen Havik, Thomas Ihle Aarhus, Iktedar Mahdi, Anke Unger, Peter Habenberger, Carsten Degenhart, Jan Eickhoff, Bert Klebl, Eirik Sundby, Bård Helge Hoff	2023	1

About Anke Unger

Anke Unger is a scholar working on Biological Psychiatry, Oncology, Pharmacology, Toxicology and Immunology, having authored 24 papers that have together received 383 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), Immune cells in cancer (4 papers), Melanoma and MAPK Pathways (3 papers), Inflammatory mediators and NSAID effects (3 papers), Quinazolinone synthesis and applications (2 papers), Cancer therapeutics and mechanisms (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Clinical Biochemistry (44 citations), Sensory Systems (20 citations), Virology (16 citations), Biochemistry (19 citations) and Microbiology (19 citations). Anke Unger has collaborated with scholars based in Germany, Norway and United Kingdom. Frequent co-authors include Stefan Laufer, Markus O. Lederer, Bert Klebl, Wolfgang Albrecht, Matthias Baumann, Jan Eickhoff, Isabel Zeitträger, Klaus Korn, Hanife Bahsi and Sabrina Wagner. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Oncotarget, Cell Host & Microbe and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact